Financial Comparison: Arcadia Biosciences (NASDAQ:RKDA) & National Beverage (NASDAQ:FIZZ)

National Beverage (NASDAQ:FIZZ) and Arcadia Biosciences (NASDAQ:RKDA) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Analyst Ratings

This is a breakdown of recent ratings and price targets for National Beverage and Arcadia Biosciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Beverage	2	0	0	0	1.00
Arcadia Biosciences	1	0	0	0	1.00

National Beverage currently has a consensus price target of $31.00, suggesting a potential upside of 4.73%. Given National Beverage’s higher possible upside, equities analysts plainly believe National Beverage is more favorable than Arcadia Biosciences.

Profitability

This table compares National Beverage and Arcadia Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
National Beverage	14.81%	32.61%	23.51%
Arcadia Biosciences	-234.53%	-183.50%	-91.25%

Risk and Volatility

National Beverage has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Arcadia Biosciences has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500.

Institutional & Insider Ownership

23.9% of National Beverage shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 74.7% of National Beverage shares are owned by insiders. Comparatively, 4.5% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares National Beverage and Arcadia Biosciences”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Beverage	$1.18 billion	2.35	$183.65 million	$1.86	15.91
Arcadia Biosciences	$4.86 million	0.14	-$2.34 million	($4.56)	-0.06

National Beverage has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than National Beverage, indicating that it is currently the more affordable of the two stocks.

Summary

National Beverage beats Arcadia Biosciences on 12 of the 12 factors compared between the two stocks.

About National Beverage

National Beverage Corp., through its subsidiaries, develops, produces, markets, and sells a portfolio of sparkling waters, juices, energy drinks, and carbonated soft drinks primarily in the United States and Canada. The company's Power+ brand portfolio offers sparkling water products under the LaCroix, LaCroix Cúrate, and LaCroix NiCola; non-carbonated flavored water under the Clear Fruit; energy drink and shots under the Rip It; juice and juice-based products under Everfresh, Everfresh Premier Varietals, and Mr. Pure; and carbonated soft drinks under Shasta and Faygo brands. It serves retailers, as well as various smaller up-and-down-the-street accounts through the take-home, convenience, and food-service distribution channels. National Beverage Corp. was incorporated in 1985 and is headquartered in Fort Lauderdale, Florida.

About Arcadia Biosciences

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.